Stelljes M, Raffel S, Alakel N, Wasch R, et al. Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL. J Clin Oncol 2024;42:273-282.
PMID: 37883727